Childhood lymphoma and bone interaction

Yıl 2010, Cilt: 37 Sayı: 1, 75 - 79, 01.03.2010

Kenan Haspolat Murat Söker

Öz

In pediatric lymphomas (Non-Hodgkin\'s lymphoma and Hodgkin\'s disease), changing in bone metabolism can be seen, both because of the disease itself or applied che­motherapeutics. In this article, bone affections in two fre­quently seen pediatric tumoral diseases are discussed.

Anahtar Kelimeler

Childhood lymphoma, bone, interaction

Çocukluk çağı lenfomaları ve kemik etkilenmesi

Öz

Çocukluk çağı lenfomalarında (Hodgkin dışı lenfoma ve Hodgkin hastalığında) hastalığın kendisi veya uygulanan kemoterapötikler nedeniyle kemik metabolizmasında de­ğişiklikler görülebilir. Bu makalede çocukluk çağında sık görülen bu iki tümöral hastalığın kemikler üzerine etkileri derlenmiştir.

Anahtar Kelimeler

Çocukluk çağı lenfoması, kemik, et­kilenme

Kaynakça

• Büyükpamukçu M. Hodgkin Dışı Lenfomalar. Klinik Geli- şim 2007;2:44-48.
• Sevinir B, Büyükpamukçu M. Çocukluk çağı lenfomaları. Katkı Pediatri Dergisi 1995;4:476.
• Rosenthal H, Kolb R, Gratz KF, Reiter A, Galanski M. Bone manifestations in non-Hodgkins lymphoma in childhood and adolescence. Radiologe 2000;40:737-744.
• Gürmen N. Çocukluk çağında görülen primer ve sekonder malign kemik tümörlerinde radyolojik bulgular. Katkı 1985;6:63-71.
• Hesseling PB, Hough SF, Nel ED, Van Riet FA, Beneke T, Wessels G. Bone mineral density in long-term survivors of childhood cancer. Int J Cancer Suppl.1998;11:44-47.
• Lanzkowsky P. Hodgkin Disease. In: Lanzkowsky P ed. Manual of Pediatric Hematology and Oncology. 4th edn. San Diego: Elsevier Academic Pres, 2005;453-90.
• Arikoski P, Komulainen J. Development of bone mineral density in children with cancer. Pediatric Endocrinology. LWPES/ESPE. 6th. Joint meeting. Montreal. 6-10, 2001;3- 172.
• Nysom K, Holm K, Michaelsen K, Hertz H, Müller J, Mol- gaard C. Bone mass after treatment of malignant lymphoma in childhood. Med Pediatr Oncol 2001; 37: 518-524.
• Brigham BA, Bunn PA, Horton JE et al. Skeletal manifes- tations in cutaneous T–cell lymphomas. Arch Dermatol 1982;118:461-467.
• Sala A, Talsma D, Webber C, Posgate S, Atkinson S, Barr R. Bone mıneral status after treatment of malignant lym- phoma in childhood and adolescence. Eur J Cancer Care 2007;16:373-379.
• Köseoğlu V, Büyükpamukçu M, Bayhan H. Lenfoma tanı- sıyla tedavi edilmiş çocuklarda kemik mineral dansitesi ve serum osteokalsin, carboxyterminal propeptid type I pro- collagen ve ICTP düzeyleri. X. Pediatrik Onkoloji Kongre- si. 22-24 Ekim 1998.Ankara S:91.
• Redman JR, Bajorunas DR,Wong G et al. Bone mineraliza- tion in women following succesful treatment of Hodgkin’s disease. Am J Med 1988; 85:65-72.
• Bluemke DA, Zerhouni EA. MRI of avascular necrosis of bone. Top Magn Reson Imaging 1996;8:231-246.
• Frisch B, Bartl R. Osteoporosis. In: Frisch B, Bartl R,eds. Biopsy interpretation of bone and bone marrow. London, 1999:62-69.
• Morakkabati N, Strunk H, Gutjahr P. MRI diagnosis and fol- low-up of bilateral necrosis of the humeral head as a com- plication after chemotherapy. Aktuelle Radiol 1997;7:41- 44.
• Brooks PM. Rheumatic manifestations of neoplasia. Curr Opin Rheumatol 1992;4:90-93.
• Georgescu L, Quinn GC, Schwartzman S, Paget SA. Lym- phoma in patients with rheumatoid arthritis. Semin Arthritis Rheum 1997;26:794-804.
• Seda H, Alarcon GS. Musculoskeletal syndromes associated with malignancies. Curr Opin Rheumatol 1995;7:48-53.
• Kohout A, Resl M, Bácová M. Pulmonary changes in rheu- matoid arthritis. Cesk Patol 2001;37:105-7.
• Falcini F, Bardare M, Cimaz R, Lippi A, Corona F. Arthritis as a presenting feature of non-Hodgkin’s lymphoma. Arch Dis Child 1998;78:367-370.
• Trapani S, Grisolia F, Simonini G, Calabri GB, Falcini F. Incıdence of occult cancer in children presenting with mus- culoskeletal symptoms. a 10-year survey in a pediatric rheu- matology unit. Semin Arthritis Rheum 2000;9:348-359.
• Wilson S, Brooks PM. Rheumatic manifestations of neopla- sia. Curr Opin Rheumatol 1993;5:99-103.
• Gaudin P, Juvin R. Rozand Y, et al: Skeletal involvement as the initial disease manifestation in Hodgkin’s disease: a review of 6 cases. J Rheumatol 1992;19:146-152.
• Felix R, Hofsetter W, Cecchini MG. Recent developments in the understanding of the pathophsiology of osteopetrosis. Eur J Endocrinol 1996;134:143-156.
• Hashino S, Hirota G, Hasegawa M, et al. Peripheral T-cell lymphoma in a patient with osteopetrosis. Ann Hematol. 2001;80:376-378.
• Shibuya H, Suzuki T, Matsubara S, Suzuki S. Non-Hodg- kins lymphoma in a patient with osteopetrosis. Lymhology. 1986;19:90-92.
• Doğru D, Çamur S, Öztürk R . Pediatrik onkolojik aciller. Katkı 1995;4:639-642.
• Syed MA, Horwitz MJ, Tedesco MB, Garcia A,Wisniewski SR, Stewart AF. Parathyrold hormone related protein stim- ulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy. J.Clin Endocrinol Metab. 2001;86:1525-1531.
• Vergin C, Atlıhan F. Kemiğin non-hodgkin lenfoması. İzmir Devlet Hast Tıp Derg 1993;3:41-50.
• Kremer R, Shustik C, Tabak T, Papavasiliou V, Goltzman D. Parathyroid hormone related peptide in hematologic malig- nancies. Am J Med 1996;100:406-411.
• Motellon JL, Jimenez FJ, de Miguel F. Relationship of plas- ma bone cytokines with hypercalcemia in cancer patients. Clin Chim Acta 2000;302:59-68.
• Sezer MT, Duranay M . Hiperkalsemi. Klinik Serileri 1992;3:27-29.
• Haspolat K. Hiperkalsemi. II. Ulusal Pediatrik Endokrino- loji Kongresi, İzmir, 1997. s:111- 9.
• Quinn JM, Athanasou NA. Tumour infiltrating macrophag- es are capable of bone resorption. J Cell Sci 1992;101:681- 686.
• Mundy GR. Hypercalcemia in hematologic malignancies and in solid tumors associated with extensive localized bone destruction. In: Favus MJ, ed. Primer on the Meta- bolic Bone Diseases and Disorders of Mineral Metabolism. 2nd edn. Philadelphia. Lippincott-Raven, 1999: p.173.